Cargando…

Zolpidem Activation of Alpha 1-Containing GABA(A) Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons

Introduction: High frequency neuronal activity in the cerebral cortex can be induced by noxious stimulation during surgery, brain injury or poisoning. In this scenario, it is essential to block cortical hyperactivity to protect the brain against damage, e.g., by using drugs that act as positive allo...

Descripción completa

Detalles Bibliográficos
Autores principales: Neumann, Elena, Rudolph, Uwe, Knutson, Daniel E., Li, Guanguan, Cook, James M., Hentschke, Harald, Antkowiak, Bernd, Drexler, Berthold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333667/
https://www.ncbi.nlm.nih.gov/pubmed/30687091
http://dx.doi.org/10.3389/fphar.2018.01523
_version_ 1783387594220896256
author Neumann, Elena
Rudolph, Uwe
Knutson, Daniel E.
Li, Guanguan
Cook, James M.
Hentschke, Harald
Antkowiak, Bernd
Drexler, Berthold
author_facet Neumann, Elena
Rudolph, Uwe
Knutson, Daniel E.
Li, Guanguan
Cook, James M.
Hentschke, Harald
Antkowiak, Bernd
Drexler, Berthold
author_sort Neumann, Elena
collection PubMed
description Introduction: High frequency neuronal activity in the cerebral cortex can be induced by noxious stimulation during surgery, brain injury or poisoning. In this scenario, it is essential to block cortical hyperactivity to protect the brain against damage, e.g., by using drugs that act as positive allosteric modulators at GABA(A) receptors. Yet, cortical neurons express multiple, functionally distinct GABA(A) receptor subtypes. Currently there is a lack of knowledge which GABA(A) receptor subtypes would be a good pharmacological target to reduce extensive cortical activity. Methods: Spontaneous action potential activity was monitored by performing extracellular recordings from organotypic neocortical slice cultures of wild type and GABA(A)R-α1(H101R) mutant mice. Phases of high neuronal activity were characterized using peri-event time histograms. Drug effects on within-up state firing rates were quantified via Hedges’ g. Results: We quantified the effects of zolpidem, a positive modulator of GABA(A) receptors harboring α1-subunits, and the experimental benzodiazepine SH-053-2′F-S-CH3, which preferably acts at α2/3/5- but spares α1-subunits. Both agents decreased spontaneous action potential activity but altered the firing patterns in different ways. Zolpidem reduced action potential firing during highly active network states. This action was abolished by flumazenil, suggesting that it was mediated by benzodiazepine-sensitive GABA(A) receptors. SH-053-2′F-S-CH3 also attenuated neuronal activity, but unlike zolpidem, failed to reduce high frequency firing. To confirm that zolpidem actions were indeed mediated via α1-dependent actions, it was evaluated in slices from wild type and α(H101R) knock-in mice. Inhibition of high frequency action potential firing was observed in slices from wild type but not mutant mice. Conclusion: Our results suggest that during episodes of scarce and high neuronal activity action potential firing of cortical neurons is controlled by different GABA(A) receptor subtypes. Exaggerated firing of cortical neurons is reduced by positive modulation of α1-, but not α2/3/5-subunit containing GABA(A) receptors.
format Online
Article
Text
id pubmed-6333667
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63336672019-01-25 Zolpidem Activation of Alpha 1-Containing GABA(A) Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons Neumann, Elena Rudolph, Uwe Knutson, Daniel E. Li, Guanguan Cook, James M. Hentschke, Harald Antkowiak, Bernd Drexler, Berthold Front Pharmacol Pharmacology Introduction: High frequency neuronal activity in the cerebral cortex can be induced by noxious stimulation during surgery, brain injury or poisoning. In this scenario, it is essential to block cortical hyperactivity to protect the brain against damage, e.g., by using drugs that act as positive allosteric modulators at GABA(A) receptors. Yet, cortical neurons express multiple, functionally distinct GABA(A) receptor subtypes. Currently there is a lack of knowledge which GABA(A) receptor subtypes would be a good pharmacological target to reduce extensive cortical activity. Methods: Spontaneous action potential activity was monitored by performing extracellular recordings from organotypic neocortical slice cultures of wild type and GABA(A)R-α1(H101R) mutant mice. Phases of high neuronal activity were characterized using peri-event time histograms. Drug effects on within-up state firing rates were quantified via Hedges’ g. Results: We quantified the effects of zolpidem, a positive modulator of GABA(A) receptors harboring α1-subunits, and the experimental benzodiazepine SH-053-2′F-S-CH3, which preferably acts at α2/3/5- but spares α1-subunits. Both agents decreased spontaneous action potential activity but altered the firing patterns in different ways. Zolpidem reduced action potential firing during highly active network states. This action was abolished by flumazenil, suggesting that it was mediated by benzodiazepine-sensitive GABA(A) receptors. SH-053-2′F-S-CH3 also attenuated neuronal activity, but unlike zolpidem, failed to reduce high frequency firing. To confirm that zolpidem actions were indeed mediated via α1-dependent actions, it was evaluated in slices from wild type and α(H101R) knock-in mice. Inhibition of high frequency action potential firing was observed in slices from wild type but not mutant mice. Conclusion: Our results suggest that during episodes of scarce and high neuronal activity action potential firing of cortical neurons is controlled by different GABA(A) receptor subtypes. Exaggerated firing of cortical neurons is reduced by positive modulation of α1-, but not α2/3/5-subunit containing GABA(A) receptors. Frontiers Media S.A. 2019-01-09 /pmc/articles/PMC6333667/ /pubmed/30687091 http://dx.doi.org/10.3389/fphar.2018.01523 Text en Copyright © 2019 Neumann, Rudolph, Knutson, Li, Cook, Hentschke, Antkowiak and Drexler. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Neumann, Elena
Rudolph, Uwe
Knutson, Daniel E.
Li, Guanguan
Cook, James M.
Hentschke, Harald
Antkowiak, Bernd
Drexler, Berthold
Zolpidem Activation of Alpha 1-Containing GABA(A) Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons
title Zolpidem Activation of Alpha 1-Containing GABA(A) Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons
title_full Zolpidem Activation of Alpha 1-Containing GABA(A) Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons
title_fullStr Zolpidem Activation of Alpha 1-Containing GABA(A) Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons
title_full_unstemmed Zolpidem Activation of Alpha 1-Containing GABA(A) Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons
title_short Zolpidem Activation of Alpha 1-Containing GABA(A) Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons
title_sort zolpidem activation of alpha 1-containing gaba(a) receptors selectively inhibits high frequency action potential firing of cortical neurons
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333667/
https://www.ncbi.nlm.nih.gov/pubmed/30687091
http://dx.doi.org/10.3389/fphar.2018.01523
work_keys_str_mv AT neumannelena zolpidemactivationofalpha1containinggabaareceptorsselectivelyinhibitshighfrequencyactionpotentialfiringofcorticalneurons
AT rudolphuwe zolpidemactivationofalpha1containinggabaareceptorsselectivelyinhibitshighfrequencyactionpotentialfiringofcorticalneurons
AT knutsondaniele zolpidemactivationofalpha1containinggabaareceptorsselectivelyinhibitshighfrequencyactionpotentialfiringofcorticalneurons
AT liguanguan zolpidemactivationofalpha1containinggabaareceptorsselectivelyinhibitshighfrequencyactionpotentialfiringofcorticalneurons
AT cookjamesm zolpidemactivationofalpha1containinggabaareceptorsselectivelyinhibitshighfrequencyactionpotentialfiringofcorticalneurons
AT hentschkeharald zolpidemactivationofalpha1containinggabaareceptorsselectivelyinhibitshighfrequencyactionpotentialfiringofcorticalneurons
AT antkowiakbernd zolpidemactivationofalpha1containinggabaareceptorsselectivelyinhibitshighfrequencyactionpotentialfiringofcorticalneurons
AT drexlerberthold zolpidemactivationofalpha1containinggabaareceptorsselectivelyinhibitshighfrequencyactionpotentialfiringofcorticalneurons